Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,78 NOK | +8,53% | +6,33% | -26,26% |
14/05 | Transcript : Nykode Therapeutics AS, Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Nykode Therapeutics AS rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
Vakgebied
Aantal werknemers: 172
Verkoop per activiteit
NOK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Vaccines and Immunotherapies
100,0
%
| 69 | 100,0 % | 136 | 100,0 % | +97,76% |
Verkoop per regio
NOK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 69 | 100,0 % | 136 | 100,0 % | +97,76% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 47 | 01-01-07 | |
Michael Engsig
CEO | Chief Executive Officer | - | 01-03-07 |
Harald Gurvin
DFI | Director of Finance/CFO | 49 | 03-05-21 |
Chief Tech/Sci/R&D Officer | 50 | 01-06-21 | |
Chief Tech/Sci/R&D Officer | - | 01-08-17 | |
Siri Torhaug
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Mette Husbyn
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-17 |
Mona Welschof
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-13 |
Louise Stubbe
LAW | General Counsel | - | 01-01-22 |
Peter Fatum
PRN | Corporate Officer/Principal | - | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | - |
Director/Board Member | 64 | - | |
Director/Board Member | - | - | |
Chairman | 69 | 22-12-21 | |
Director/Board Member | 56 | - | |
Birgitte Volck
BRD | Director/Board Member | 61 | 05-05-21 |
Director/Board Member | 52 | - | |
Anders Tuv
BRD | Director/Board Member | 46 | - |
Elaine Sullivan
BRD | Director/Board Member | 63 | 13-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 326 546 444 | 179 598 448 ( 55,00 %) | 0 | 55,00 % |
Bedrijfsgegevens
Nykode Therapeutics ASA
Oslo Science Park Gaustadalléen 21
0349, Oslo
+47 22 95 81 93
http://www.nykode.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,26% | 490 mln. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |
- Beurs
- Aandelen
- Koers VACC
- Onderneming Nykode Therapeutics